Ashland Inc

Research Ashland Inc (ASH) on Bullrun: valuation model: 47.3% overvalued, market cap USD 3.38B, P/E 65.3, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Ashland Inc as 47.3% overvalued; latest market cap is USD 3.38B; P/E is 65.3; dividend yield is 1.7%.

Peer valuation comparison

Latest P/E is 65.26x versus a Basic Materials sector median of 17.36x (275.8% above).

Latest dividend yield is 1.68% versus a Basic Materials sector median of 2.19% (23.3% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 1.82B-USD 845.00MUSD 36.00M30.1%-18.23USD 215.00MUSD 1.38BUSD 1.90B
FY2024USD 2.11BUSD 169.00MUSD 325.00M29.2%3.36USD 300.00MUSD 1.35BUSD 2.87B
FY2023USD 2.19BUSD 178.00MUSD 124.00M30.5%3.31USD 417.00MUSD 1.31BUSD 3.10B
FY2022USD 2.39BUSD 927.00MUSD 80.00M34.7%16.41USD 646.00MUSD 1.27BUSD 3.22B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 3.38B65.32.3%1.67
20252025-12-31USD 2.68Bn/a2.8%1.67
20242024-12-31USD 3.37Bn/a2.3%1.62
20232023-12-29USD 4.28B25.91.8%1.51
20222022-12-30USD 5.83Bn/a1.2%1.32
20212021-12-31USD 6.13B32.01.1%1.18

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.67 USD, yield 1.7%.

YearDividends/share
FY20251.64 USD
FY20241.58 USD
FY20231.44 USD
FY20221.27 USD

About Ashland Inc

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals;

Related stock research

Other Basic Materials stocks

Frequently asked questions

Is Ashland Inc overvalued or undervalued?

Bullrun's valuation model currently marks Ashland Inc as 47.3% overvalued.

What is Ashland Inc's market cap?

Ashland Inc's market capitalization is USD 3.38B.

What is Ashland Inc's P/E ratio?

Ashland Inc's price-to-earnings (P/E) ratio is 65.3.

Does Ashland Inc pay a dividend?

Ashland Inc has a dividend yield of 1.7%.

What does Ashland Inc do?

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals.